Hot Swollen Foot in a Man With Diabetes: Image IQ

Poll

Acute stage Charcot foot is seen in a 55-year-old man with type 2 diabetes mellitus. He has a history of peripheral neuroarthropathy with a 1-week history of a hot, swollen right foot. A radiograph of the foot revealed acute stage Charcot neuroarthropathy.

Acute stage Charcot foot is seen in a 55-year-old man with type 2 diabetes mellitus. He has a history of peripheral neuroarthropathy with a 1-week history of a hot, swollen right foot. A radiograph of the foot revealed acute stage Charcot neuroarthropathy.

Which of the following statements about Charcot foot is/are true?

A. Misdiagnosis can lead to ulceration, loss of mobility and limb, and death.
B. Charcot neuroarthropathy usually affects persons with diabetes mellitus.
C. The acute stage resembles cellulitis.
D. Chronic Charcot foot resembles osteomyelitis.
E. All of the above are true.
F. A and B
Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Diabetes

FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Diabetes

Patient Care Editorial Staff
February 14th 2025
Article

Merilog joins two long-acting insulin biosimilar products approved in 2021, bringing the total to three insulin biosimilars available in the United States.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Diabetes Caution: FDA Warns of Risk of Missing Critical Alerts from Smartphone-Compatible Diabetes Devices / image credit ©Yurii/stock.adobe.com

Diabetes Caution: FDA Warns of Risk of Missing Critical Alerts from Smartphone-Compatible Diabetes Devices

Grace Halsey
February 6th 2025
Article

Hardware or software changes as well as user adjustments may disable or mute alerts for elevated glycemia, medication use, and other diabetes management essentials, the agency said.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

More than Half of US Adults Eligible for Semaglutide: Daily Dose / image credit: ©New Africa/AdobeStock

More than Half of US Adults Eligible for Semaglutide: Daily Dose

Sydney Jennings
December 9th 2024
Article

Your daily dose of the clinical news you may have missed.

New Trial Backs Intensive Blood Pressure Target for Adults with T2D: Daily Dose / image credit: ©New Africa/AdobeStock

New Trial Backs Intensive Blood Pressure Target for Adults with T2D: Daily Dose

Sydney Jennings
December 2nd 2024
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.